Mat Treatment Algorithm

The asam national practice guideline 2020 focused update is intended to inform and empower clinicians health system administrators criminal justice system administrators and policymakers who are interested in implementing evidence based practices to improve outcomes for individuals with oud.

Mat treatment algorithm. The case for mat mat is the use of medications in combination with counseling and behavioral therapies to provide a whole patient approach to the treatment of substance use disorders samhsa research indicates that methadone and buprenorphine have a strong evidence base supporting their clinical effectiveness. Medication assisted treatment mat is the use of medications in combination with counseling and behavioral therapies for the treatment of opioid use disorders oud which is effective in the. Outcomes associated with treatment using methadone buprenorphine or naltrexone as well as counseling without medication treatment program factors associated with positive outcomes patient characteristics associated with positive outcomes and. Mat for opioid addiction.

Medication assisted treatment guidelines for opioid use disorders mat work group r. Given the importance of opioid substitution therapy to treatment success and the need to reduce the risk. Medication treatment to persons less than 16 years of age with an oud. It is recommended that a comprehensive screening for drugs misuse be completed upon entering opioid treatment programs.

Guidelines from the american academy of pediatrics support the use of medication for the treatment of opioid use disorder in children and adolescents. Opioid treatment screening guidelines for hubs. Naloxone is also added to buprenorphine to decrease the likelihood of diversion and misuse of the combination drug product. Medications used in mat are approved by the food and drug administration fda and mat programs are clinically driven and tailored to meet each patient s needs.

Journey about treatment beliefs but rather a consolidation of current evidence that can guide the treatment safety efficacy and payment models driving the treatment of opioid use disorders moving forward. Corey waller md ms 9 17 2014 state of michigan. The mat study will answer key questions about. Samhsa s division of pharmacologic therapies dpt part of samhsa s center for substance abuse treatment csat manages the day to day oversight activates required to implement federal regulations surrounding the use medications approved by the food and drug administration fda.

Naloxone is an fda approved medication used in medication assisted treatment mat to counter opioid overdose reversing the toxic effects of the overdose. A doctor can prescribe naloxone to. The primary goal of mat is to improve overall patient wellness. Federal statutes regulations and guidelines govern medication assisted treatment mat for opioid addiction.